Citation: | Zi WANG, Bing-bin ZHAO, Jiu-liang ZHAO, Hua CHEN, Guo-tao MA, Jian-zhou LIU, Wen-qian CHEN, Chi SHAO, Jin-zhi LAI, Wei CHENG, Qi MIAO, Xiao-feng ZENG, Feng-chun ZHANG, Jin-jing LIU. Arthritis, Dyspnea and Hemoptysis on Exertion[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 347-353. DOI: 10.3969/j.issn.1674-9081.20190181 |
[1] |
徐希奇,荆志成. 第六届世界肺高血压会议:聚焦肺高血压定义与诊断分类更新[J]. 协和医学杂志,2018,9:197-201.
|
[2] |
Cervera R, Serrano R, Pons-Estel GJ, et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period:a multicentre prospective study of 1000 patients[J]. Ann Rheum Dis, 2015, 74:1011-1018. https://pubmed.ncbi.nlm.nih.gov/24464962/
|
[3] |
Vnlü O, Zuily S, Erkan D. The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus[J]. Eur J Rheumatol, 2016, 3:75-84. DOI: 10.5152/eurjrheum.2015.0085
|
[4] |
Chung WS, Lin CL, Chang SN, et al. Systemic lupus erythematosus increases the risks of deep vein thrombosis and pulmonary embolism:a nationwide cohort study[J]. J Thromb Haemost, 2014, 12:452-458. DOI: 10.1111/jth.12518
|
[5] |
Tektonidou MG, Andreoli L, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults[J]. Ann Rheum Dis, 2019, 78:1296-1304. DOI: 10.1136/annrheumdis-2019-215213
|
[6] |
Kanakis MA, Kapsimali V, Vaiopoulos AG, et al. The lung in the spectrum of antiphospholipid syndrome[J]. Clin Exp Rheumatol, 2013, 31:452-457.
|
[7] |
Prashanth P, Mukhaini MK. Primary antiphospholipid syndrome with recurrent coronary thrombosis, acute pulmonary thromboembolism and intracerebral hematoma[J]. J Invasive Cardiol, 2009, 21:E254-E258. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=Open J-Gate000001859680
|
[8] |
Zifman E, Rotman-Pikielny P, Berlin T, et al. Insertion of inferior vena cava filters in patients with the antiphospholipid syndrome[J]. Semin Arthritis Rheum, 2009, 38:472-477. DOI: 10.1016/j.semarthrit.2008.01.016
|
[9] |
Kaplan SD, Chartash EK, Pizzarello RA, et al. Cardiac manifestations of the antiphospholipid syndrome[J]. Am Heart J, 1992, 124:1331-1338. DOI: 10.1016/0002-8703(92)90420-Z
|
[10] |
Dhibar DP, Sahu KK, Varma SC, et al. Intra-cardiac thrombus in antiphospholipid antibody syndrome:An unusual cause of fever of unknown origin with review of literature[J]. J Cardiol Cases, 2016, 14:153-156. DOI: 10.1016/j.jccase.2016.07.005
|
[11] |
Cianciulli TF, Saccheri MC, Redruello HJ, et al. Right atrial thrombus mimicking myxoma with pulmonary embolism in a patient with systemic lupus erythematosus and secondary antiphospholipid syndrome[J]. Tex Heart Inst J, 2008, 35:454-457. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2607098/
|
[12] |
Khalid U, Hirudayaraj P, Lakkis N, et al. Left atrial thrombus mimicking a myxoma in a patient with systemic lupus erythematosus[J]. Hellenic J Cardiol, 2014, 55:167-170. https://www.ncbi.nlm.nih.gov/pubmed/24681796
|
[13] |
Willens HJ, Lowery MH, Lopez E, et al. Rapid resolution of left ventricular thrombus in antiphospholipid syndrome[J]. Echocardiography, 2003, 20:67-70. DOI: 10.1046/j.1540-8175.2003.00009.x
|
[14] |
Zahid H, Hassan S, Gul S, et al. Co-existing Bilateral Pulmonary Embolism and Intra-cardiac Mass:A Case of Catastrophic Antiphospholipid Syndrome-like Disease[J]. Cureus, 2018, 10:e3438.
|
[15] |
Tektonidou MG, Andreoli L, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults[J]. Ann Rheum Dis, 2019,78:1296-1304. DOI: 10.1136/annrheumdis-2019-215213
|
[16] |
Tselios K, Gladman DD, Urowitz MB. Systemic lupus erythematosus and pulmonary arterial hypertension:links, risks, and management strategies[J]. Open Access Rheumatol, 2016, 9:1-9. DOI: 10.2147/OARRR.S123549
|
[17] |
Lai YC, Potoka KC, Champion HC, et al. Pulmonary arterial hypertension:the clinical syndrome[J]. Circ Res, 2014, 115:115-130. DOI: 10.1161/CIRCRESAHA.115.301146
|
[18] |
Hemnes AR, Kiely DG, Cockrill BA, et al. Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute[J]. Pulm Circ, 2015, 5:435-465. DOI: 10.1086/682230
|
[19] |
Tanaka E, Harigai M, Tanaka M, et al. Pulmonary hypertension in systemic lupus erythematosus:evaluation of clinical characteristics and response to immunosuppressive treatment[J]. J Rheumatol, 2002, 29:282-287. https://www.jrheum.org/content/29/2/282
|
[20] |
Gonzalez-Lopez L, Cardona-Muñoz EG, Celis A, et al. Therapy with intermittent pulse cyclophosphamide for pulmonary hypertension associated with systemic lupus erythemato-sus[J]. Lupus, 2004, 13:105-112. DOI: 10.1191/0961203304lu509oa
|
[21] |
Sanchez O, Sitbon O, Jaïs X, et al. Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension[J]. Chest, 2006, 130:182-189. DOI: 10.1378/chest.130.1.182
|